Event Date/Time: Jul 20, 2011
End Date/Time: Jul 22, 2011
The annual Biodefense Vaccines & Therapeutics conference, scheduled for July 20-22, 2011, will once again provide the latest information on the Federal governmentâ€™s chemical, biological, radiological and nuclear (CBRN) medical countermeasures (MCM) research, development and procurement initiatives, and insights into potential legislative changes and its potential impact on the biodefense industry. The conference is the ideal venue to interact face-to-face with representatives from Federal agencies tasked with building the CBRN MCMs capacity in the United States. Year after year, the conference brings together the community to explore strategies with dealing with various challenges, share perspectives on dealing with uncertainty and establish fruitful collaboration to further the development of needed biological, chemical, radiological and nuclear (CBRN) medical countermeasures.
The 2011 conference will include the Developments in Biodefense Technology Platforms Symposium, July 20, 2011, where leading researchers from government, industry and academia will provide a briefing on the latest platforms being developed in biodefense and how these innovations are being used to address threats from emerging infectious diseases.
Tuition listings and registration for the 9th Annual Biodefense Vaccines & Therapeutics conference will be available soon. Please contact Amy Tam at 818.888.4445 ex 13 if you have any questions.